DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Esperion Therapeutics, Inc. (ESPR)
« Back to company indexESPR Chatter Timeline
Stock Ticker for ESPR
Most Active Tweeters for ESPR
| User | Tweets |
|---|---|
| @BH1377 | 9 |
| @TickerReport | 6 |
| @Clover_Research | 4 |
| @OlympiaReport | 4 |
| @YuZhu4 | 3 |
Recent Tweets for ESPR
 |
@BACScoreChanges #EsperionTherapeutics $ESPR BidaskScore is Downgraded to Held https://t.co/lZKeoDAhWl July 15th 2019, 11:07pm |
 |
@TickerReport Esperion Therapeutics $ESPR Upgraded to Hold by BidaskClub https://t.co/tnPo7tjmiB July 14th 2019, 5:07am |
 |
@OlympiaReport Esperion Therapeutics $ESPR Stock Rating Upgraded by BidaskClub https://t.co/1IELvRcS3D July 14th 2019, 5:07am |
 |
@ZolmaxNews Esperion Therapeutics Inc $ESPR Receives $72.89 Average Price Target from Analysts https://t.co/XpfwMcXAJY July 13th 2019, 1:07pm |
 |
@dakotafinancial Esperion Therapeutics Inc $ESPR Receives $72.89 Average Price Target from Analysts https://t.co/eHy6KYs8ST July 13th 2019, 1:07pm |
|
@BH1377 @Clover_Research @iamdimitre BTW, I stand corrected on my statement regarding the positive signal for $ESPR with th… https://t.co/5YOg3a6eFh July 11th 2019, 5:07pm |
 |
@Gambiste1 RT @Clover_Research: @BH1377 You have zero criticisms or concerns for an $ESPR investment? July 11th 2019, 1:07pm |
|
@BH1377 @Clover_Research I have concerns for all my investments, including $ESPR, but you haven't stated any of them, or ba… https://t.co/eWEvU5QrOG July 11th 2019, 12:07pm |
 |
@Clover_Research @BH1377 You have zero criticisms or concerns for an $ESPR investment? July 11th 2019, 12:07pm |
|
@BH1377 @Clover_Research Why would anyone make that point if they weren't trying to be negative re $ESPR? Given your acknow… https://t.co/zCF0PAoL9r July 11th 2019, 12:07pm |
|
@BH1377 Clover's reply to me regarding my $ESPR comments speaks for itself. Do your homework, read the research, don't jus… https://t.co/QtPuRfA8e1 July 11th 2019, 11:07am |
|
@BH1377 @Clover_Research You're bullish on $ESPR prospects, but post negative leaning statements that aren't true? Interes… https://t.co/IBs7l1ld7O July 11th 2019, 11:07am |
|
@BH1377 Read the criteria for $ESPR's CLEAR Outcomes Study...it's designed to succeed; data 2021-22 & results likely better… https://t.co/nqrAwHATCz July 11th 2019, 11:07am |
|
@Clover_Research @BH1377 Zetia, in combination with statins, has proved added benefit worthy of coverage. I'm bullish on $ESPR prosp… https://t.co/JO2jY7FSNJ July 11th 2019, 11:07am |
|
@BH1377 The fact is that $ESPR has two new drugs with positive P3 trials in 1000's of patients & both of these drugs are al… https://t.co/rhCAZPLn3f July 11th 2019, 11:07am |
|
@Clover_Research $ESPR "statin-intolerance" isn't a market. In fact, true intolerance hardly exists at all. And MDs should reduce do… https://t.co/jTDPeC4hXT July 11th 2019, 10:07am |
 |
@fda_tracker $ESPR Phase 2 trial w/est Jul completion date NCT03531905: https://t.co/0JYusK5Fov Trial Tracker: https://t.co/aR7q5oJwjn July 11th 2019, 9:07am |
|
@BH1377 @Clover_Research $ESPR's CEO seems to think so. He's bought 10K shares on the open mkt with his own money YTD. His… https://t.co/UWSh3zZU29 July 10th 2019, 2:07pm |
|
@Clover_Research $ESPR seems very cheap, doesn't it? https://t.co/8aBur1i6Tz July 10th 2019, 2:07pm |
 |
@ConsumerFeed Esperion Therapeutics Inc $ESPR Expected to Post Quarterly Sales of $930,000.00 https://t.co/styaKOftJ7 July 10th 2019, 1:07pm |
|
@TickerReport Esperion Therapeutics Inc $ESPR Receives $72.89 Consensus Price Target from Brokerages https://t.co/Ig9HEaZOsu July 9th 2019, 4:07am |
|
@OlympiaReport Esperion Therapeutics Inc $ESPR Expected to Post Earnings of -$1.89 Per Share https://t.co/geBJrmg9sj July 8th 2019, 11:07am |
|
@TickerReport Esperion Therapeutics Inc $ESPR Expected to Announce Earnings of -$1.89 Per Share https://t.co/zhnyRRZ6kK July 8th 2019, 11:07am |
 |
@bbnsnews Esperion Therapeutics $ESPR Downgraded by BidaskClub to “Sell” https://t.co/6ADnK8Q6lB July 7th 2019, 4:07am |
 |
@AmericanBanking Esperion Therapeutics Inc $ESPR Receives Average Recommendation of “Hold” from Analysts https://t.co/2FPOs1a4qF #stocks July 6th 2019, 2:07pm |
 |
@EnterpriseLeade Esperion Therapeutics $ESPR Downgraded by BidaskClub https://t.co/RwFP9zxV7b July 6th 2019, 7:07am |
 |
@registrarjourn Esperion Therapeutics $ESPR Downgraded by BidaskClub https://t.co/sYxoklcqTF July 6th 2019, 7:07am |
 |
@dispatchtribune Esperion Therapeutics $ESPR Downgraded by BidaskClub https://t.co/gwTRiEjyt5 July 6th 2019, 7:07am |
|
@AmericanBanking $930,000.00 in Sales Expected for Esperion Therapeutics Inc $ESPR This Quarter https://t.co/lxjmzWLI5W #stocks July 5th 2019, 4:07am |
|
@TickerReport BidaskClub Lowers Esperion Therapeutics $ESPR to Sell https://t.co/BNh8KYadXF July 5th 2019, 4:07am |
|
@Gambiste1 RT @TradeFlags: TD BUY $ESPR at 47.21, Supp 45.58 Resis 51.31 R13 HiLo 45% T1Y 89 buy 1.9 fwdPE -17.2 DIV N/A #Esperion T #stocks #trading… July 4th 2019, 7:07am |
|
@dakotafinancial Insider Buying: Esperion Therapeutics Inc $ESPR CEO Purchases 5,000 Shares of Stock https://t.co/afeG0BY9Fv July 4th 2019, 5:07am |
 |
@1MinuteStock Wondering about #sentiment indicator for $ESPR? The Short Ratio is 11.3% https://t.co/A5AE9594PW July 4th 2019, 12:07am |
 |
@TradeFlags TD BUY $ESPR at 47.21, Supp 45.58 Resis 51.31 R13 HiLo 45% T1Y 89 buy 1.9 fwdPE -17.2 DIV N/A #Esperion T #stocks… https://t.co/b9lVKEG8rM July 4th 2019, 12:07am |
|
@AmericanBanking -$1.89 EPS Expected for Esperion Therapeutics Inc $ESPR This Quarter https://t.co/tjaqR4mXjr #stocks July 3rd 2019, 9:07am |
|
@TickerReport Insider Buying: Esperion Therapeutics Inc $ESPR CEO Purchases 5,000 Shares of Stock https://t.co/XiEWUmj2oM July 3rd 2019, 4:07am |
|
@OlympiaReport Timothy M. Mayleben Purchases 5,000 Shares of Esperion Therapeutics Inc $ESPR Stock https://t.co/2aXUbT4R4u July 3rd 2019, 4:07am |
 |
@WeekHerald Esperion Therapeutics $ESPR vs. Aimmune Therapeutics $AIMT Head-To-Head Contrast https://t.co/IhvPnpEH6V July 3rd 2019, 3:07am |
 |
@TheMarketsDaily FY2020 Earnings Forecast for Esperion Therapeutics Inc Issued By Jefferies Financial Group $ESPR https://t.co/L8zt1mnplW July 3rd 2019, 2:07am |
 |
@YuZhu4 RT @haodongvli: $BHVN $ESPR: both CEOs bought 5K shares of their own stocks on secondary market, confidence game! July 2nd 2019, 4:07pm |
 |
@haodongvli $BHVN $ESPR: both CEOs bought 5K shares of their own stocks on secondary market, confidence game! July 2nd 2019, 3:07pm |
|
@YuZhu4 RT @BH1377: Second time this year $ESPR's CEO bought 5K shares with money out of his own pocket...not stock grants / awards or part of his… July 2nd 2019, 1:07pm |
|
@YuZhu4 RT @haodongvli: $ESPR it is going to be a triple digits stock in 2020, agree with its CEO who bought at $46 yesterday July 2nd 2019, 1:07pm |
 |
@MarginCall3 @jonnajarian hey, what’s up with the huge spike in $60 options call buying for $ESPR? July 2nd 2019, 11:07am |
|
@haodongvli $ESPR it is going to be a triple digits stock in 2020, agree with its CEO who bought at $46 yesterday July 2nd 2019, 10:07am |
 |
@StockBrain99 Tuesday ALL ACTIVE BUY STOP ORDERS ABOVE THE MARKET 4 TODAY already bot past 10 minutes $ESPR #stocks #news… https://t.co/nMGbnIVgWG July 2nd 2019, 10:07am |
 |
@StockBrain2010 Tuesday ALL ACTIVE BUY STOP ORDERS ABOVE THE MARKET 4 TODAY already bot past 10 minutes $ESPR #stocks #news… https://t.co/SAoDsuuTOM July 2nd 2019, 10:07am |
|
@StockBrain99 Tuesday ALL ACTIVE BUY STOP ORDERS ABOVE THE MARKET 4 TODAY already bot past 10 minutes $ESPR #stocks #news… https://t.co/vWXQ201joE July 2nd 2019, 10:07am |
|
@MarginCall3 CEO of Esperion $ESPR just bought 5,000 shares at market price Also, there is a huge options call buying at $60 st… https://t.co/26kd3lqr8u July 2nd 2019, 10:07am |
|
@OlympiaReport Esperion Therapeutics $ESPR Downgraded by ValuEngine to “Buy” https://t.co/DDQIyRzZ9i July 2nd 2019, 6:07am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.